Rifabutin triple therapy increased H pylori eradication vs. amoxicillin + omeprazole in treatment-naive patients.

Rifabutin triple therapy increased H pylori eradication vs. amoxicillin + omeprazole in treatment-naive patients.
Ann Intern Med. 2020 Sep 15;173(6):JC33
Authors: Jr JM
Abstract
SOURCE CITATION: Graham DY, Canaan Y, Maher J, et al. Rifabutin-based triple therapy (RHB-105) for Helicobacter pylori eradication: a double-blind, randomized, controlled trial. Ann Intern Med. 2020;172:795-802. 32365359.
PMID: 32926814 [PubMed - as supplied by publisher]

Source: Annals of Internal Medicine - September 14, 2020 Category: Internal Medicine Authors: Jr JM Tags: Ann Intern Med Source Type: research